Side-effects
gastro-intestinal disturbances; peripheral oedema; upper respiratory tract infection, nasopharyngitis; pain; osteoarthritis; less commonly dry mouth, anorexia, headache, drowsiness, dizziness, hypoglycaemia, osteoarthritis;
"The only alternative to Byetta in treating this autoimmune attack on GIP and GLP-1 incretins is a medication called sitagliptin (Januvia). This works by killing of the autoimmune enzyme DPP-4, the enzyme that attacks our incretins. But the treatment is a double edged sword - the main function of DPP-4 is to kill cancer cells, so by stopping DPP-4 from working we are also reducing the body's natural defence against cancer. It is for this reason that many consultants regard Januvia as a high-risk treatment and are reluctant to prescribe it."
daisy1 said:Thanks squishychickfi for that reassuring information. I would be very grateful if you would post an update on this thread occasionally as to how you are getting on (especially in the next three weeks when I have to make my decision) and if you are getting any unpleasant side effects.The trouble is it's a relatively new drug and they don't have too much feedback from patients yet.
The carcinogenic potential of sitagliptin was determined in mice and rats. In the two-year mouse
carcinogenicity study, there were no treatment-related increases in tumor incidence in any organ at all
tested doses (50, 125, 250, 500 mg/kg/day).
The Committee for Medicinal Products for Human Use (CHMP) decided that Januvia’s benefits are greater than its risks and recommended that it be given marketing authorisation.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?